Interleukin-27 levels in patients with myasthenia gravis

Abstract Interleukin-27 (IL-27), which belongs to IL-12 family, influences the function of T cells (Tregs) through regulating the expression, and function of forkhead box P3 (FoxP3). In this study, we detected the IL-27 serum levels in 59 myasthenia gravis (MG) patients and 35 healthy controls (HCs). Among them, 32 MG patients received immunoglobulin intravenous (IVIG) injections (0.4 g/kg per day for 5 consecutive days). IL-27 levels were collected before and after the treatments and subjected to a comparative study. Finally, we assessed the correlations of IL-27 levels with the clinical characteristics of MG. As a result, serum IL-27 levels were significantly higher in MG patients than those in the HCs. Meanwhile, significant reduction was detected after the IVIG treatment. IL-27 levels positively correlated with both MG activities of daily living and quantitative MG score. IL-27 may participate in the pathogenesis of MG and can be used as an early marker for the diagnosis and prognosis of MG. In addition, IL-27 can be used as a target for MG treatment through the regulation of specific immune signaling and maintaining immune homeostasis.

• Publication year

  2020

• Venue

  Translational Neuroscience

• Publication date

  2020-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1515/tnsci-2020-0134PMID 33312724PMCID 7706121
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intravenous immunoglobulin mediates anti-inflammatory effects in peripheral blood mononuclear cells by inducing autophagy

  2020cited by this paper
• Intravenous immunoglobulin (IVIg) or IVIg‐treated macrophages reduce DSS‐induced colitis by inducing macrophage IL‐10 production

  2019cited by this paper
• Transcriptional repressor Blimp1 regulates follicular regulatory T‐cell homeostasis and function

  2018cited by this paper
• IL-27: a potential biomarker for responders to glatiramer acetate therapy.

  2017cited by this paper
• Intravenous immunoglobulin (IVIG) treatment modulates peripheral blood Th17 and regulatory T cells in recurrent miscarriage patients: Non randomized, open-label clinical trial.

  2017cited by this paper
• Treg-specific IL-27Rα deletion uncovers a key role for IL-27 in Treg function to control autoimmunity

  2017cited by this paper
• Regulatory T cells in multiple sclerosis and myasthenia gravis

  2017cited by this paper
• Increased interleukin-27 cytokine expression in the central nervous system of multiple sclerosis patients

  2017cited by this paper
• IVIG-mediated effector functions in autoimmune and inflammatory diseases

  2017cited by this paper
• Analysis of serum interleukin-27 and interleukin-35 concentrations in patients with Guillain-Barré syndrome.

  2017cited by this paper
• Myasthenia Gravis.

  2016cited by this paper
• Interleukin-27 as a Novel Therapy for Inflammatory Bowel Disease: A Critical Review of the Literature

  2016cited by this paper
• Imbalance of circulating CD4(+)CXCR5(+)FOXP3(+) Tfr-like cells and CD4(+)CXCR5(+)FOXP3(-) Tfh-like cells in myasthenia gravis.

  2016cited by this paper
• Serum interleukin-27 expression in patients with myasthenia gravis.

  2015cited by this paper
• IL-27-induced modulation of autoimmunity and its therapeutic potential.

  2015cited by this paper
• An IL-27/Lag3 axis enhances Foxp3+ regulatory T cell suppressive function and therapeutic efficacy

  2015influential reference
• Blockade of interleukin-27 signaling reduces GVHD in mice by augmenting Treg reconstitution and stabilizing Foxp3 expression.

  2015cited by this paper
• Intravenous immunoglobulin exerts reciprocal regulation of Th1/Th17 cells and regulatory T cells in Guillain–Barré syndrome patients

  2014cited by this paper
• IL-31 Associated with Coronary Artery Lesion Formation in Kawasaki Disease

  2014cited by this paper
• A Novel Role for IL-27 in Mediating the Survival of Activated Mouse CD4 T Lymphocytes

  2013cited by this paper
• Serum IL-21 levels decrease with glucocorticoid treatment in myasthenia gravis

  2013cited by this paper
• This information is current as Lymphocytes Survival of Activated Mouse CD 4 T A Novel Role for IL-27 in Mediating the Cheroutre and Mitchell Kronenberg

  2013cited by this paper
• Impaired regulatory function in circulating CD4(+)CD25(high)CD127(low/-) T cells in patients with myasthenia gravis.

  2012cited by this paper
• Increased levels of interleukin-27 in patients with rheumatoid arthritis.

  2011cited by this paper
• IL-27 promotes T cell–dependent colitis through multiple mechanisms

  2011cited by this paper
• [Expression of IL-21 in the peripheral blood of myasthenia gravis patients and its correlation with anti-AChR-Ab class switch].

  2010cited by this paper
• Possible roles of IL-27 in the pathogenesis of psoriasis.

  2010cited by this paper
• The Autoimmune Regulator AIRE in Thymoma Biology: Autoimmunity and Beyond

  2010cited by this paper
• Effects of inflammatory cytokine IL-27 on the activation of fibroblast-like synoviocytes in rheumatoid arthritis

  2010cited by this paper
• Prednisolone Treatment Induces Tolerogenic Dendritic Cells and a Regulatory Milieu in Myasthenia Gravis Patients1

  2009cited by this paper
• Expression of autoimmune regulator gene (AIRE) and T regulatory cells in human thymomas

  2007cited by this paper
• Activated CD4+CD25+ T cells selectively kill B lymphocytes.

  2006cited by this paper
• Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans

  2006cited by this paper
• Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis.

  2005cited by this paper
• Myasthenia Gravis

  1975influential reference

• Interleukin-27 and Autoimmune Disorders: A Compressive Review of Immunological Functions

  2024cites this paper